Valuation: QuidelOrtho Corporation

Market Cap 1.24B 1.09B 1B 925M 1.74B 120B 1.78B 11.99B 4.72B 58.66B 4.67B 4.57B 202B P/E 2026 *
-11.4x
P/E 2027 * -114x
Enterprise Value 3.61B 3.16B 2.91B 2.69B 5.06B 348B 5.17B 34.82B 13.7B 170B 13.57B 13.27B 587B EV / Sales 2026 *
1.33x
EV / Sales 2027 * 1.27x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day-3.78%
1 week-3.72%
Current month+0.43%
1 month+33.97%
3 months+38.39%
6 months-46.26%
Current year-38.41%
1 week 17.19
Extreme 17.19
19.03
1 month 11.84
Extreme 11.84
19.8
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
89.11
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
7/6/26 Other

Chief Financial Officer

0 0%
7/1/26 Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
6/25/26 Free

Director

19,599 0.0289%
Change 5-day change 1-year change 3-year change Capi.($)
-3.70%-3.72%-34.07%-78.84% 1.24B
-1.46%+0.58%+15.63%-20.90% 17.53B
-6.27%-3.41%+0.47%+82.98% 1.67B
-1.34%-5.93%-37.77%+12.26% 1.01B
-4.06%+5.84%-27.53%-52.68% 672M
-7.46%-0.30%-40.81%-57.56% 576M
-1.12%-4.07%+35.03%-53.65% 453M
-1.26%+0.64%-54.16%-58.79% 387M
-3.29%+16.11%+47.89% - 332M
+7.76%+6.36%-18.49%-20.78% 338M
Average -2.22%+1.23%-11.38%-27.55% 2.42B
Weighted average by Cap. -2.02%+4.06%+6.47%-18.25%

Financials

2026 *2027 *
Net sales 2.71B 2.37B 2.19B 2.01B 3.8B 261B 3.88B 26.12B 10.27B 128B 10.18B 9.95B 440B 2.8B 2.45B 2.26B 2.08B 3.92B 270B 4.01B 26.98B 10.61B 132B 10.51B 10.28B 454B
Net income -156M -136M -126M -116M -218M -15.01B -223M -1.5B -591M -7.35B -585M -572M -25.3B -81.93M -71.6M -66.07M -60.9M -115M -7.89B -117M -790M -311M -3.86B -308M -301M -13.3B
Net Debt 2.37B 2.07B 1.91B 1.76B 3.32B 228B 3.39B 22.83B 8.98B 112B 8.9B 8.7B 385B 2.3B 2.01B 1.85B 1.71B 3.22B 221B 3.29B 22.16B 8.71B 108B 8.63B 8.44B 373B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-07-17 US$17.59 -3.59% 443,655
26-07-16 US$18.24 +0.05% 1,136,877
26-07-15 US$18.23 +3.23% 1,347,139
26-07-14 US$17.66 -1.29% 784,679
26-07-13 US$17.89 -2.08% 1,123,060
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
18.24USD
Average target price
20.50USD
Spread / Average Target
+12.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock